Shigella: Difference between revisions
From IDWiki
Shigella
m (Text replacement - "[[Cellular shape::" to "[[Shape::") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Background== |
==Background== |
||
*[[Stain::Gram-negative]] [[Shape::bacillus]] |
*[[Stain::Gram-negative]] [[Shape::bacillus]] within the family [[Family::Enterobacteriaceae]] and order [[Order::Enterobacterales]] |
||
**Most closely related to [[Escherichia coli]] |
|||
*Species include [[Shigella dysenteriae]], [[Shigella sonnei]], [[Shigella flexneri]], and [[Shigella boydii]] |
|||
**At least 40 serotypes |
|||
*Strains that encode Shiga toxin include [[Shigella dysenteriae]] serotype 1 (most common), [[Shigella flexneri]] type 2a, [[Shigella dysenteriae]] type 4, and [[Shigella sonnei]] |
|||
*Automated methods frequently misidentify as [[Escherichia coli]], so needs phenotypic testing with serology |
*Automated methods frequently misidentify as [[Escherichia coli]], so needs phenotypic testing with serology |
||
*Needs azithromycin susceptibility to be requested specifically, if it is resistant to others |
*Needs [[azithromycin]] susceptibility to be requested specifically, if it is resistant to others |
||
**However, there are no standardized breakpoints, so you have to use the epidemiologic cutoff values |
**However, there are no standardized breakpoints, so you have to use the epidemiologic cutoff values |
||
*Extensively drug resistant (XDR) Shigella is resistant to [[ampicillin]], [[fluoroquinolones]], [[third-generation cephalosporins]], [[azithromycin]], and [[co-trimoxazole]] |
|||
== |
==Clinical Manifestations== |
||
* Most commonly causes self-limited diarrheal illness with watery or loose stools |
|||
⚫ | |||
* Disease may be more severe, including high fever, abdominal cramps, abdominal tenderness, tenesmus, mucoid stools, and [[hematochezia]] |
|||
* Complications of severe disease include [[bacteremia]], [[pseudomembranous colitis]], [[toxic megacolon]], [[intestinal perforation]], [[hemolysis]], and [[hemolytic-uremic syndrome]] |
|||
** Bacteremia more common in neonates and patients with malnutrition |
|||
* Serotype 1 is more likely to cause severe illness |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
== Diagnosis == |
|||
* Molecular testing with PCR of stool is the most common method of diagnosing diarrheal illness |
|||
* Culture of stool or rectal swab |
|||
** Mass spectrometry cannot reliably differentiate from [[Escherichia coli]], so needs biochemical identification |
|||
== Management == |
|||
* Supportive care and oral rehydration |
|||
* Avoid antidiarrheal or antimotility agents, which can prolong the clinical course and increase risk of severe disease |
|||
* If severe disease or immunocompromised, should be treated empirically with antimicrobials |
|||
** Ideally should be directed by susceptibility data |
|||
** [[Azithromycin]] for 3 days or [[ceftriaxone]] for 2 to 5 days are good empiric options, though resistance is increasing |
|||
** Other options include [[ciprofloxacin]] for 3 days, [[ampicillin]] for 5 days, or [[trimethoprim-sulfamethoxazole]] for 5 days |
|||
*** Avoid [[fluoroquinolones]] if MIC ≥0.12 μg/mL |
|||
*** Avoid [[amoxicillin]], which may not be well-absorbed |
|||
⚫ | |||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
||
[[Category:Gastrointestinal infections]] |
Latest revision as of 20:33, 5 May 2023
Background
- Gram-negative bacillus within the family Enterobacteriaceae and order Enterobacterales
- Most closely related to Escherichia coli
- Species include Shigella dysenteriae, Shigella sonnei, Shigella flexneri, and Shigella boydii
- At least 40 serotypes
- Strains that encode Shiga toxin include Shigella dysenteriae serotype 1 (most common), Shigella flexneri type 2a, Shigella dysenteriae type 4, and Shigella sonnei
- Automated methods frequently misidentify as Escherichia coli, so needs phenotypic testing with serology
- Needs azithromycin susceptibility to be requested specifically, if it is resistant to others
- However, there are no standardized breakpoints, so you have to use the epidemiologic cutoff values
- Extensively drug resistant (XDR) Shigella is resistant to ampicillin, fluoroquinolones, third-generation cephalosporins, azithromycin, and co-trimoxazole
Clinical Manifestations
- Most commonly causes self-limited diarrheal illness with watery or loose stools
- Disease may be more severe, including high fever, abdominal cramps, abdominal tenderness, tenesmus, mucoid stools, and hematochezia
- Complications of severe disease include bacteremia, pseudomembranous colitis, toxic megacolon, intestinal perforation, hemolysis, and hemolytic-uremic syndrome
- Bacteremia more common in neonates and patients with malnutrition
- Serotype 1 is more likely to cause severe illness
Post-Infectious Complications
Diagnosis
- Molecular testing with PCR of stool is the most common method of diagnosing diarrheal illness
- Culture of stool or rectal swab
- Mass spectrometry cannot reliably differentiate from Escherichia coli, so needs biochemical identification
Management
- Supportive care and oral rehydration
- Avoid antidiarrheal or antimotility agents, which can prolong the clinical course and increase risk of severe disease
- If severe disease or immunocompromised, should be treated empirically with antimicrobials
- Ideally should be directed by susceptibility data
- Azithromycin for 3 days or ceftriaxone for 2 to 5 days are good empiric options, though resistance is increasing
- Other options include ciprofloxacin for 3 days, ampicillin for 5 days, or trimethoprim-sulfamethoxazole for 5 days
- Avoid fluoroquinolones if MIC ≥0.12 μg/mL
- Avoid amoxicillin, which may not be well-absorbed